Founded
Address
Polaris Venture Partners Inc
1000 Winter Street
Suite 3350
Waltham, MA 02451
United States
Phone
Website
Industry
Recent investment activity
KANDO id: 31159
Corporate information
Official name
Polaris Venture Partners Incorporated
Registration country
Company type
Multistage venture capital investors with focus Technology, Healthcare and ConsumerFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Polaris Venture Partners VI LP | Venture | 2010 | USD | 233,800,000 |
| Polaris Venture Partners V LP | Venture | 2006 | USD | 1,000,000,000 |
| Polaris Venture Partners IV | Venture | 2002 | USD | 900,000,000 |
| Polaris Venture Partners III | Venture | 2000 | USD | 500,000,000 |
| Polaris Venture Partners II | Venture | 1998 | USD | 175,000,000 |
| Polaris Venture Partners LP | Venture | 1996 | USD | 80,000,000 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 166| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
| 170 Systems | Series A led the round | |||||
| 480 Biomedical Inc | Series A | |||||
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series F | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series E | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series C Initial investment | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series B Follow-on investment | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series A Initial investment | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | N/A | |||
| Accordant Health Services Inc | N/A | |||||
| Acusphere Inc | Pharmaceutical firm developing porous micro-particle delivery systems. | N/A | ||||
|
Adimab LLC | Developer of a human antibody discovery platform in yeast. | Series D | |||
|
Adnexus Therapeutics Inc | A biotechnology company focused on developing new class of therapeutic compounds. | N/A | |||
| Advanced Inhalation Research Inc | N/A | |||||
| Advion BioSciences Inc (Advion Inc) | Medical device company innovating purpose-built products that improve workflows for the life science industry. | N/A | ||||
|
Aepona Ltd | Aepona is a software platform pioneer and global market leader in bringing Mobile Intelligence to Cloud Computing. | Series C | |||
|
Akamai Technologies Inc | Cloud-based services for optimizing web and mobile content and applications, online HD video, and secure commerce. | N/A | |||
| Alimera Sciences Inc | Biopharmaceutical company. | Series B Initial investment | ||||
| Allaire Corp | N/A | |||||
| Alnylam Pharmaceuticals Inc | N/A | |||||
| AlphaBlox Corp Inc | N/A | |||||
| American Superconductor Corp | N/A | |||||
| Antenna Software Inc | Provider of mobile workers with secure access to corporate data and applications. | N/A | ||||
| Apnex Medical Inc | N/A | |||||
| Archivas Inc | Series C | |||||
| Archus Orthopedics Inc | Spinal and orthopedic implant and instrument company. | Series C |
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
|
Michael Hirshland | Resolute Ventures |